|
REFERENCE TITLE: pharmacists; independent testing; treatment; requirements |
|
State of Arizona Senate Fifty-sixth Legislature First Regular Session 2023
|
|
SB 1460 |
|
|
|
Introduced by Senator Shope
|
An Act
amending title 32, chapter 18, article 3, Arizona Revised Statutes, by adding section 32-1979.04; relating to the Arizona state board of pharmacy.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 32, chapter 18, article 3, Arizona Revised Statutes, is amended by adding section 32-1979.04, to read:
32-1979.04. Independent testing; treatment; health conditions; requirements
A. A pharmacist may independently order testing and initiate and perform treatment for eligible persons who test positive for any of the following health conditions:
1. Influenza.
2. A respiratory infection.
3. A condition related to an Emerging or existing public health threat identified by the department of health services for which a statewide standing order, rule or executive order is issued.
B. A pharmacist who conducts tests to determine the need for treatment pursuant to subsection A of this section shall do so at a pharmacy or other facility that has obtained a certificate of waiver from the centers for medicare and medicaid services pursuant to the federal clinical laboratory improvement amendments.
C. Pharmacists shall use evidence-based clinical guidelines published by the centers for disease control and prevention or the infectious diseases society of America or other clinically recognized recommendations in providing patient treatment pursuant to subsection A of this section.
D. An eligible person must meet criteria for treatment based on current clinical guidelines, when available, or evidence-based research findings that specify the following:
1. Patient inclusion and exclusion criteria.
2. Explicit medical referral criteria.
E. A patient shall be referred to the patient's primary care provider if the patient either:
1. Is not eligible for patient treatment pursuant to this section and presents with differential symptoms.
2. Does not respond to the initial treatment provided pursuant to this section.